Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Singular Health is an Australian publicly traded medical technology company focused on software for medical imaging visualization, interoperability, and patient engagement. Its core offering is the 3DICOM ecosystem, which includes a volumetric rendering platform that converts standard CT, MRI, and PET scans into interactive 3D models, a medical file transfer protocol for secure image sharing, and cloud-based AI capabilities. The company markets its products to healthcare providers, medical educators, and patients rather than developing therapeutics. Singular Health has obtained U.S. FDA 510(k) clearance for 3DICOM MD and appears to be commercializing its platform internationally, including in the United States. The business is best characterized as a commercial-stage digital health and medtech platform company rather than a biotech or pharma developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Singular Health.